Ankara, Turkey – In a statement, the Ministry of Health said: “the opinion that production is close for the other 4 candidates, where the production phase for the first vaccine has been moved to the facility with GMP (Good Manufacturing procedures) certification for vaccine candidates whose animal experiments have been completed, has been clarified in the evaluations.”the statement said. In addition, the Scientific Council agreed to expand the Covid-19 Tests and increase the number of tests, except for suspicious cases of contact.

Our coronavirus Science Board met under the chairmanship of the Minister of Health Dr Fahrettin Koca and evaluated the latest developments related to the epidemic.

First, the point reached in the vaccine development studies conducted almost simultaneously with the world in our country has been discussed. The 5 closest vaccines to the first human applications were discussed with the members of the Scientific Board, the details of the first vaccine produced as a research product and the stages to be followed in the other 4 vaccines were evaluated. In the facility with GMP (Good Manufacturing procedures) certification for vaccine candidates whose animal experiments have been completed, the opinion that production is also close for the other 4 candidates, where the production stage for the first vaccine has been switched to, has become clear in the evaluations.

Repeating the “social immunity and incidence screening” study conducted in cooperation with TUIK, the issue of detecting immunity by measuring antibody level and re-evaluating the active case rate with PCR testing was considered as another agenda item of the meeting. It was agreed that repeating the study would be useful in terms of evaluating the course of the pandemic with clearer lines.

Our screening tests policy was also evaluated with the members of the Science Board. By expanding the tests, it was agreed to further increase the number of tests, except for suspicious cases of contact.